Abeona Therapeutics Q2 EPS $1.71 Beats $(0.39) Estimate

Abeona Therapeutics (NASDAQ: ABEO) reported quarterly earnings of $1.71 per share which beat the analyst consensus estimate of $(0.39) by 543.01 percent. This is a 757.69 percent increase over losses of $(0.26) per share from the same period last year.